iBio, Inc.

IBIONASDAQHealthcare● Active

$1.73

$-0.09(-4.95%)

Market Cap$27315788

P/E Ratio—

52W High$3.82

52W Low$0.56

Avg Volume939K

Open$1.87

Beta1.27

Forecast Market Cap PE Ratio

iBio, Inc.（IBIO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ibio · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

Buy

4 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 4 · 买入占比: 75.0%

12 个月目标价

High

$5.00

Consensus

$5.00

+189.0% upside

Low

$5.00

Median: $5 · Last Close: $1.73

iBio, Inc.（IBIO）的分析师共识为 Buy，基于过去 3 个月内 4 位华尔街分析师的评级。IBIO 的 12 个月平均目标价为 $5.00，相对当前价 $1.73 代表 +189.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$1.78	↑ 3.11%	$1.77	$1.80

1-day model range: $1.77–$1.8. Peak: $1.8 (+3.11%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$1	$1	$1	-44.5%
2028	$1	$1	$1	-56.9%
2029	$1	$1	$1	-61.7%
2030	$1	$1	$1	-63.8%
2031	$1	—	$1	-64.8%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

21%8%71%

3Buy

1Neutral

10Sell

RSI (14)63.0Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IBIO · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$1.82SELL

MA 10$1.85SELL

MA 20$1.74SELL

MA 50$1.83SELL

MA 100$2.09SELL

MA 200$1.69BUY

Current $IBIO · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$1.81SELL

EMA 10$1.81SELL

EMA 20$1.79SELL

EMA 50$1.85SELL

EMA 100$1.88SELL

EMA 200$1.66BUY

Current $IBIO · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-04-09	Chardan Capital	Maintains	Buy→Buy
2026-03-18	Chardan Capital	Maintains	Buy→Buy
2026-02-12	Chardan Capital	Maintains	Buy→Buy
2025-06-25	Chardan Capital	Maintains	Buy→Buy
2025-05-06	Chardan Capital	Maintains	Buy→Buy
2025-05-05	Chardan Capital	Maintains	Buy→Buy
2024-06-03	Chardan Capital	Maintains	Buy→Buy
2022-10-07	Cantor Fitzgerald	Downgrade ↓	Overweight→Neutral
2021-11-29	JMP Securities	Maintains	Outperform→Outperform
2021-01-22	Cantor Fitzgerald	Maintains	Overweight→Overweight

Chardan Capital2026-04-09

Maintains

Buy→Buy

Chardan Capital2026-03-18

Maintains

Buy→Buy

Chardan Capital2026-02-12

Maintains

Buy→Buy

Chardan Capital2025-06-25

Maintains

Buy→Buy

Chardan Capital2025-05-06

Maintains

Buy→Buy

Chardan Capital2025-05-05

Maintains

Buy→Buy

Chardan Capital2024-06-03

Maintains

Buy→Buy

Cantor Fitzgerald2022-10-07

Downgrade ↓

Overweight→Neutral

JMP Securities2021-11-29

Maintains

Outperform→Outperform

Cantor Fitzgerald2021-01-22

Maintains

Overweight→Overweight

Wall Street analysts have recently issued updated ratings on iBio, Inc. (IBIO) stock. Of the recent 12 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover IBIO.

分析师推荐趋势

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

IBIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$0M

↓ 28.0% YoY

Revenue Next Year

$0M

↓ 33.3% YoY

EPS This Year

$-0.34

EPS Next Year

$-0.32

↓ 5.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IBIO EPS of $-0.34 for the current fiscal year, based on estimates from 3 analysts. The IBIO revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

IBIO 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IBIO 的共识目标价为 $5.00（+189.0% 上行空间），分析师共识为 Buy。

IBIO 的短期预测（明日）为 $1.78（+3.11%）。 IBIO 对 2027 年的股价预测均值为 $1。 IBIO 对 2030 年的预测区间为 $1–$1。

iBio, Inc. 在 NASDAQ 上市，代码 IBIO。IBIO 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

IBIO 预测 · 8 个问题

根据 4 位华尔街分析师，IBIO 的 12 个月平均目标价为 $5.00，最高 $5.00、最低 $5.00。若有图表，中位目标价可在上方查看。相对当前价 $1.73，隐含约 +189.0% 的上行空间。

IBIO 目标价IBIO 分析师目标价IBIO 12个月目标价目标价 IBIO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.